Sign in

CIK 0002020932

  • Non-accelerated filer
  • Emerging growth company

AgomAb Therapeutics NV

Sign in to watch
Ticker
AGMB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Belgium
Entity type
Other
Phone
+32 33023530
Business address
POSTHOFLEI 1/6, ANTWERPEN, Belgium, 2600
Open-market buys, last 90 days
$592,149
in 7 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$592,149. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-13 Epstein David R Director Purchase +5,000 $5.99 $30K 45,000
2026-11-13 Epstein David R Director Purchase +20 $6.00 $120 45,020
2026-11-13 Epstein David R Director Purchase +5,000 $5.75 $29K 50,020
2026-11-13 Epstein David R Director Purchase +4,960 $6.02 $30K 54,980
2026-11-05 Epstein David R Director Purchase +5,000 $6.81 $34K 30,000
2026-11-05 Epstein David R Director Purchase +5,000 $6.91 $35K 35,000
2026-11-05 Epstein David R Director Purchase +5,000 $6.98 $35K 40,000
2026-10-21 Epstein David R Director Purchase +5,000 $8.86 $44K 20,000
2026-10-21 Epstein David R Director Purchase +5,000 $8.90 $45K 25,000
2026-10-08 Epstein David R Director Purchase +5,000 $8.90 $45K 15,000
2026-10-06 Knotnerus Tim Jasper Chief Executive Officer Purchase +5,000 $8.70 $44K 21,823
2026-10-06 Kemula Pierre Thadee Victor Chief Financial Officer Purchase +3,000 $8.67 $26K 3,000
2026-10-06 Kemula Pierre Thadee Victor Chief Financial Officer Purchase +5,000 $8.57 $43K 8,000
2026-10-06 Kemula Pierre Thadee Victor Chief Financial Officer Purchase +2,000 $8.54 $17K 10,000
2026-10-06 Epstein David R Director Purchase +5,000 $8.70 $44K 10,000
2026-10-05 Knotnerus Tim Jasper Chief Executive Officer Purchase +6,000 $8.48 $51K 16,823
2026-10-05 Epstein David R Director Purchase +5,000 $8.57 $43K 5,000
2026-09-11 Garcia Marino Director Grant or award · Stock Option (Right to Buy) +57,482 57,482
2026-09-11 Patel Naimish Director Grant or award · Stock Option (Right to Buy) +56,328 56,328

Page 1 of 1 · 19 trades